SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $78,552,270 |
| Positions | 4 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Evolv Technologies Holdings, Inc. | EVLV | COM CL A | $26,622,000 | 4,590,000 |
| Horizon Quantum Holdings Ltd | Unresolved | CL A ORD SHS | $25,405,896 | 915,198 |
| Recursion Pharmaceuticals, Inc. | RXRX | CL A | $21,803,910 | 5,941,120 |
| Definium Therapeutics, Inc. (MindMed) | DFTX | COM SHS | $4,720,464 | 100,350 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.